Pathology of TB/COVID-19 Co-Infection: The phantom menace.
COVID-19
Cytokines
Immunopathology
Inflammation
Tuberculosis
Journal
Tuberculosis (Edinburgh, Scotland)
ISSN: 1873-281X
Titre abrégé: Tuberculosis (Edinb)
Pays: Scotland
ID NLM: 100971555
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
14
07
2020
revised:
10
09
2020
accepted:
10
11
2020
pubmed:
28
11
2020
medline:
25
2
2021
entrez:
27
11
2020
Statut:
ppublish
Résumé
Tuberculosis (TB) and coronavirus disease 2019 (COVID-19) are currently the two main causes of death among infectious diseases. There is an increasing number of studies trying to elucidate the interactions between Mycobacterium tuberculosis and SARS-CoV-2. Some of the first case reports point to a worsening of respiratory symptoms in co-infected TB/COVID-19 individuals. However, data from the cohort studies has shown some conflicting results. This study proposes to conduct a systematic review on the current literature on TB/COVID-19 co-infection cohorts, evaluating clinical and epidemiological data, focusing on its implications to the immune system. From an immunological perspective, the TB/COVID-19 co-infection has the potential to converge in a "perfect storm". The disorders induced by each pathogen to the immunomodulation tend to induce an unbalanced inflammatory response, which can promote the progression and worsening of both diseases. Understanding the nature of the interactions between M. tuberculosis and SARS-CoV-2 will be crucial for the development of therapeutic strategies against co-infection.
Identifiants
pubmed: 33246269
pii: S1472-9792(20)30187-6
doi: 10.1016/j.tube.2020.102020
pmc: PMC7669479
pii:
doi:
Substances chimiques
Inflammation Mediators
0
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102020Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Références
J Infect. 2020 Jul;81(1):e6-e12
pubmed: 32283162
Tuber Lung Dis. 1993 Feb;74(1):6-11
pubmed: 8495021
Ann Pharmacother. 1996 Nov;30(11):1298-303
pubmed: 8913413
Immunol Rev. 2015 Mar;264(1):6-24
pubmed: 25703549
JAMA. 1990 Jul 11;264(2):165-6
pubmed: 2355436
Pulmonology. 2020 Jul - Aug;26(4):233-240
pubmed: 32411943
Front Cell Infect Microbiol. 2018 May 15;8:158
pubmed: 29868514
J Infect Dis. 2005 Oct 1;192(7):1201-9
pubmed: 16136463
Cell Mol Immunol. 2018 Mar;15(3):216-225
pubmed: 29176747
Immunol Cell Biol. 2007 Feb-Mar;85(2):103-11
pubmed: 17213830
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32482787
Thorax. 2000 Jan;55(1):32-8
pubmed: 10607799
Eur Respir J. 2020 Apr 23;55(4):
pubmed: 32241828
Eur Respir J. 2020 Oct 1;56(4):
pubmed: 32586885
PLoS One. 2013 Nov 29;8(11):e80302
pubmed: 24312209
Pharmaceut Med. 2020 Aug;34(4):223-231
pubmed: 32535732
Monaldi Arch Chest Dis. 2020 Jul 22;90(3):
pubmed: 32697060
Arthritis Rheumatol. 2020 Jul;72(7):1059-1063
pubmed: 32293098
J Med Virol. 2021 Jan;93(1):194-196
pubmed: 32687228
Eur Respir Rev. 2018 Feb 28;27(147):
pubmed: 29491034
Trop Med Health. 2020 May 13;48:32
pubmed: 32425653
Int J Tuberc Lung Dis. 2001 Oct;5(10):887-93
pubmed: 11605880
Medicine (Baltimore). 1991 Nov;70(6):384-97
pubmed: 1956280
N Engl J Med. 2020 Aug 27;383(9):885-886
pubmed: 32530584
J Immunol. 2018 Mar 15;200(6):2090-2103
pubmed: 29440351
J Immunol. 2010 Jul 1;185(1):15-22
pubmed: 20562268
Cell. 2020 May 28;181(5):1016-1035.e19
pubmed: 32413319
J Allergy Clin Immunol. 2001 Apr;107(4):664-70
pubmed: 11295656
J Immunol. 2007 Mar 1;178(5):2661-5
pubmed: 17312107
Front Immunol. 2013 Jan 07;3:411
pubmed: 23308075
Eur Respir J. 2020 Jul 9;56(1):
pubmed: 32457198
Chest. 1990 Jun;97(6):1439-45
pubmed: 2112081
Clin Exp Immunol. 2004 Sep;137(3):460-8
pubmed: 15320894
Eur Respir J. 2020 Jul 9;56(1):
pubmed: 32444399
Am J Med. 1957 Jun;22(6):894-903
pubmed: 13424554
Tuberculosis (Edinb). 2016 May;98:62-76
pubmed: 27156620
Int J Tuberc Lung Dis. 2020 May 1;24(5):544-545
pubmed: 32398212
Clin Immunol. 2020 Jun;215:108448
pubmed: 32353634
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21
pubmed: 32446305
Infect Dis (Lond). 2020 Nov - Dec;52(12):902-907
pubmed: 32808838
J Pathol. 2014 Nov;234(3):338-50
pubmed: 24979482
Cell Mol Immunol. 2020 May;17(5):533-535
pubmed: 32203188
Int J Environ Res Public Health. 2020 Aug 05;17(16):
pubmed: 32764417
Eur Respir J. 2009 May;33(5):956-73
pubmed: 19407047
Mucosal Immunol. 2011 May;4(3):271-8
pubmed: 21430653
BMC Pulm Med. 2019 Nov 6;19(1):201
pubmed: 31694601
Turk J Med Sci. 2020 Apr 17;50(SI-1):620-632
pubmed: 32299202
Front Immunol. 2020 May 01;11:827
pubmed: 32425950
Virus Res. 2007 Sep;128(1-2):1-8
pubmed: 17532082
Front Immunol. 2020 May 27;11:962
pubmed: 32536917
Medicine (Baltimore). 2010 Jan;89(1):53-61
pubmed: 20075705
Semin Immunol. 2014 Dec;26(6):543-51
pubmed: 25453229
Lancet. 2017 Sep 30;390(10102):1618-1619
pubmed: 28980964
Int J Tuberc Lung Dis. 1998 Jan;2(1):10-5
pubmed: 9562106
Nat Rev Microbiol. 2018 Feb;16(2):80-90
pubmed: 29109555
Chest. 1993 Mar;103(3):673-7
pubmed: 8449050
Eur Respir J. 2020 Aug 13;56(2):
pubmed: 32513784
Clin Immunol. 2020 May;214:108393
pubmed: 32222466
BMC Infect Dis. 2019 Jul 29;19(1):667
pubmed: 31357936
Am Rev Respir Dis. 1966 May;93(5):769-85
pubmed: 5296012
Cell Death Differ. 2020 May;27(5):1451-1454
pubmed: 32205856
J Leukoc Biol. 2009 Dec;86(6):1393-401
pubmed: 19773555